ROCKWELL MEDICAL, INC. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
ROCKWELL MEDICAL, INC. (RMTI) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $403.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2026-08-13
- ROCKWELL MEDICAL, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-06-30 was $403.00K, a 5.50% increase year-over-year.
- ROCKWELL MEDICAL, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-03-31 was $479.00K, a 7.64% increase year-over-year.
- ROCKWELL MEDICAL, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-09-30 was $532.00K, a 65.73% increase year-over-year.
- ROCKWELL MEDICAL, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-06-30 was $382.00K, a 13.02% increase year-over-year.
- ROCKWELL MEDICAL, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2025 was $1.82M, a 40.56% increase from fiscal 2024.
- ROCKWELL MEDICAL, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2024 was $1.29M, a 38.63% increase from fiscal 2023.
- ROCKWELL MEDICAL, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2023 was $932.00K, a 195.87% increase from fiscal 2022.
- ROCKWELL MEDICAL, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $315.00K, a 66.60% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $403.00K 10-Q · filed 2026-08-13 | $882.00K derived: sum of 2 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $479.00K 10-Q · filed 2026-08-13 | |||||
| 2025-12-31 | $1.82M 10-K · filed 2026-03-26 | |||||
| 2025-09-30 | $532.00K 10-Q · filed 2025-11-12 | $914.00K derived: sum of 2 quarters · filed 2026-08-13 | $1.36M derived: sum of 3 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $382.00K 10-Q · filed 2026-08-13 | $827.00K derived: sum of 2 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $445.00K 10-Q · filed 2026-08-13 | |||||
| 2024-12-31 | $1.29M 10-K · filed 2026-03-26 | |||||
| 2024-09-30 | $321.00K 10-Q · filed 2025-11-12 | $659.00K derived: sum of 2 quarters · filed 2025-11-12 | $910.00K derived: sum of 3 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $338.00K 10-Q · filed 2025-11-12 | $589.00K derived: sum of 2 quarters · filed 2025-11-12 | ||||
| 2024-03-31 | $251.00K 10-Q · filed 2025-11-12 | |||||
| 2023-12-31 | $932.00K 10-K · filed 2025-03-20 | |||||
| 2023-09-30 | $212.00K 10-Q · filed 2024-11-12 | $521.00K derived: sum of 2 quarters · filed 2024-11-12 | $714.00K derived: sum of 3 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $309.00K 10-Q · filed 2024-11-12 | $502.00K derived: sum of 2 quarters · filed 2024-11-12 | ||||
| 2023-03-31 | $193.00K 10-Q · filed 2024-11-12 | |||||
| 2022-12-31 | $315.00K 10-K · filed 2024-03-21 | |||||
| 2022-09-30 | $176.00K 10-Q · filed 2023-11-14 | $273.00K derived: sum of 2 quarters · filed 2023-11-14 | $94.00K derived: sum of 3 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $97.00K 10-Q · filed 2023-11-14 | -$82.00K derived: sum of 2 quarters · filed 2023-11-14 | ||||
| 2022-03-31 | -$179.00K 10-Q · filed 2023-11-14 | |||||
| 2021-12-31 | $943.00K 10-K · filed 2023-03-30 | |||||
| 2021-09-30 | $361.00K 10-Q · filed 2022-11-14 | $794.00K derived: sum of 2 quarters · filed 2022-11-14 | $558.00K derived: sum of 3 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $433.00K 10-Q · filed 2022-11-14 | $197.00K derived: sum of 2 quarters · filed 2022-11-14 | ||||
| 2021-03-31 | -$236.00K 10-Q · filed 2022-11-14 | |||||
| 2020-12-31 | $475.00K 10-K · filed 2022-04-08 | |||||
| 2020-09-30 | $250.00K 10-Q · filed 2021-11-15 | -$1.21M derived: sum of 2 quarters · filed 2021-11-15 | -$276.00K derived: sum of 3 quarters · filed 2021-11-15 | $780.96K derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | -$1.46M 10-Q · filed 2021-11-15 | -$1.46M 10-Q · filed 2020-08-10 | -$526.00K derived: sum of 2 quarters · filed 2021-11-15 | $530.96K derived: sum of 3 quarters · filed 2021-11-15 | $1.41M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-03-31 | $935.00K 10-Q · filed 2021-11-15 | $934.85K 10-Q · filed 2020-05-11 | $1.99M derived: sum of 2 quarters · filed 2021-11-15 | $2.87M derived: sum of 3 quarters · filed 2021-11-15 | $4.37M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2019-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $1.93M derived: sum of 2 quarters · filed 2021-03-31 | $3.43M derived: sum of 3 quarters · filed 2021-03-31 | $4.95M 10-K · filed 2021-03-31 | $4.95M 10-K · filed 2020-03-17 | |
| 2019-09-30 | $876.00K 10-Q · filed 2020-11-09 | $876.41K 10-Q · filed 2019-11-12 | $2.38M derived: sum of 2 quarters · filed 2020-11-09 | $3.90M 10-Q · filed 2019-11-12 | $5.86M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $1.50M 10-Q · filed 2020-11-09 | $1.50M 10-Q · filed 2019-08-09 | $3.02M 10-Q · filed 2019-08-09 | $4.98M derived: sum of 3 quarters · filed 2020-11-09 | $5.60M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-03-31 | $1.52M 10-Q · filed 2020-11-09 | $1.52M 10-Q · filed 2019-05-10 | $3.48M derived: sum of 2 quarters · filed 2020-11-09 | $4.09M derived: sum of 3 quarters · filed 2020-11-09 | $5.46M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2018-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $2.58M derived: sum of 2 quarters · filed 2020-03-17 | $3.94M derived: sum of 3 quarters · filed 2020-03-17 | $4.39M 10-K · filed 2020-03-17 | ||
| 2018-09-30 | $614.58K 10-Q · filed 2019-11-12 | $1.98M derived: sum of 2 quarters · filed 2019-11-12 | $2.43M 10-Q · filed 2019-11-12 | $6.10M derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | $1.37M 10-Q · filed 2019-08-09 | $1.81M 10-Q · filed 2019-08-09 | $5.48M derived: sum of 3 quarters · filed 2019-08-09 | $6.55M derived: sum of 4 quarters · filed 2019-08-09 | ||
| 2018-03-31 | $446.00K 10-Q · filed 2019-05-10 | $616.27K 10-Q · filed 2018-05-10 | $4.12M derived: sum of 2 quarters · filed 2019-05-10 | $5.19M derived: sum of 3 quarters · filed 2019-05-10 | $6.26M derived: sum of 4 quarters · filed 2019-05-10 | |
| 2017-12-31 | $3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $4.74M derived: sum of 2 quarters · filed 2019-03-18 | $5.81M derived: sum of 3 quarters · filed 2019-03-18 | $6.95M 10-K · filed 2019-03-18 | $3.86M 10-K · filed 2018-03-15 | |
| 2017-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $2.14M derived: sum of 2 quarters · filed 2017-11-08 | $3.28M 10-Q · filed 2017-11-08 | $4.74M derived: sum of 4 quarters · filed 2018-03-15 | ||
| 2017-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $2.20M 10-Q · filed 2017-08-09 | $3.66M derived: sum of 3 quarters · filed 2018-03-15 | $5.15M derived: sum of 4 quarters · filed 2018-03-15 | ||
| 2017-03-31 | $1.13M 10-Q · filed 2017-05-09 | $2.59M derived: sum of 2 quarters · filed 2018-03-15 | $4.08M derived: sum of 3 quarters · filed 2018-03-15 | $5.53M derived: sum of 4 quarters · filed 2018-03-15 | ||
| 2016-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $2.94M derived: sum of 2 quarters · filed 2018-03-15 | $4.40M derived: sum of 3 quarters · filed 2018-03-15 | $5.98M 10-K · filed 2018-03-15 | ||
| 2016-09-30 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $2.93M derived: sum of 2 quarters · filed 2016-11-07 | $4.52M 10-Q · filed 2016-11-07 | $6.23M derived: sum of 4 quarters · filed 2018-03-15 | ||
| 2016-06-30 | $1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $3.04M 10-Q · filed 2016-08-09 | $4.75M derived: sum of 3 quarters · filed 2018-03-15 | $5.85M derived: sum of 4 quarters · filed 2018-03-15 | ||
| 2016-03-31 | $1.59M 10-Q · filed 2016-05-10 | $3.30M derived: sum of 2 quarters · filed 2018-03-15 | $4.40M derived: sum of 3 quarters · filed 2018-03-15 | $5.57M derived: sum of 4 quarters · filed 2018-03-15 | ||
| 2015-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $2.81M derived: sum of 2 quarters · filed 2018-03-15 | $3.98M derived: sum of 3 quarters · filed 2018-03-15 | $5.19M 10-K · filed 2018-03-15 | ||
| 2015-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $2.27M derived: sum of 2 quarters · filed 2015-11-09 | $3.49M 10-Q · filed 2015-11-09 | $4.97M derived: sum of 4 quarters · filed 2017-03-15 | ||
| 2015-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $2.38M 10-Q · filed 2015-08-04 | $3.87M derived: sum of 3 quarters · filed 2017-03-15 | $4.91M derived: sum of 4 quarters · filed 2017-03-15 | ||
| 2015-03-31 | $1.22M 10-Q · filed 2015-05-07 | $2.70M derived: sum of 2 quarters · filed 2017-03-15 | $3.74M derived: sum of 3 quarters · filed 2017-03-15 | $4.78M derived: sum of 4 quarters · filed 2017-03-15 | ||
| 2014-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $2.53M derived: sum of 2 quarters · filed 2017-03-15 | $3.56M derived: sum of 3 quarters · filed 2017-03-15 | $4.60M 10-K · filed 2017-03-15 | ||
| 2014-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $2.08M derived: sum of 2 quarters · filed 2014-11-10 | $3.11M 10-Q · filed 2014-11-10 | $3.97M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $2.07M 10-Q · filed 2014-07-31 | $2.93M derived: sum of 3 quarters · filed 2016-02-29 | $4.01M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-31 | $1.04M 10-Q · filed 2014-05-12 | $1.90M derived: sum of 2 quarters · filed 2016-02-29 | $2.97M derived: sum of 3 quarters · filed 2016-02-29 | $3.96M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $860.76K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.94M derived: sum of 2 quarters · filed 2016-02-29 | $2.93M derived: sum of 3 quarters · filed 2016-02-29 | $3.89M 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $2.07M derived: sum of 2 quarters · filed 2013-11-05 | $3.03M 10-Q · filed 2013-11-05 | $3.89M derived: sum of 4 quarters · filed 2015-03-03 | ||
| 2013-06-30 | $990.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $1.95M 10-Q · filed 2013-08-01 | $2.81M derived: sum of 3 quarters · filed 2015-03-03 | $3.75M derived: sum of 4 quarters · filed 2015-03-03 | ||
| 2013-03-31 | $960.14K 10-Q · filed 2013-05-08 | $1.82M derived: sum of 2 quarters · filed 2015-03-03 | $2.76M derived: sum of 3 quarters · filed 2015-03-03 | $3.77M derived: sum of 4 quarters · filed 2015-03-03 | ||
| 2012-12-31 | $860.11K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $1.80M derived: sum of 2 quarters · filed 2015-03-03 | $2.81M derived: sum of 3 quarters · filed 2015-03-03 | $3.90M 10-K · filed 2015-03-03 | ||
| 2012-09-30 | $941.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $1.95M derived: sum of 2 quarters · filed 2012-11-09 | $3.04M 10-Q · filed 2012-11-09 | $3.95M derived: sum of 4 quarters · filed 2014-03-07 | ||
| 2012-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $2.10M 10-Q · filed 2012-08-07 | $3.01M derived: sum of 3 quarters · filed 2014-03-07 | $3.74M derived: sum of 4 quarters · filed 2014-03-07 | ||
| 2012-03-31 | $1.09M 10-Q · filed 2012-05-07 | $1.99M derived: sum of 2 quarters · filed 2014-03-07 | $2.73M derived: sum of 3 quarters · filed 2014-03-07 | |||
| 2011-12-31 | $905.27K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $1.64M derived: sum of 2 quarters · filed 2014-03-07 | $3.47M 10-K · filed 2014-03-07 | |||
| 2011-09-30 | $732.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $2.56M 10-Q · filed 2011-11-04 | ||||
| 2011-06-30 | $1.83M 10-Q · filed 2011-08-05 | |||||
| 2010-12-31 | $3.05M 10-K · filed 2013-03-18 | |||||
| 2009-12-31 | $1.80M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |